Skip to content

Asset Entities ASST Medical Device — Total Assets

Other segment segments

Corporate & Other
$1.08B
Asset Management
$1.28M

Similar metrics at other companies

Abbott logo
ABTMedical Devices — Total Assets
$10.98B+9.5%
Johnson & Johnson logo
JNJMedical Devices — Total Assets
$86.18B+1.3%
Knowles logo
KNMedTech & Specialty Audio — Total Assets
$388.5M-2.0%
Emerson Electric logo
EMRIntelligent Devices — Total Assets
$11.96B
Medtronic logo
MDTTotal Assets
$93.03B+1.5%
Johnson & Johnson logo
JNJInnovative Medicine — Total Assets
$78.12B+33.0%

Other financials

Income statement

See full
Revenue$2.8M+1,516%
Operating income-$313.1M-7,588%
Net income-$265.9M-6,993%
EPS (diluted)-$4.53-175%

Balance sheet

See full
Cash & equivalents$95.1M+982%
Total debt$3.4M
Total equity$714.8M+3,548%
Total assets$1.1B+21,931%

Cash flow

See full
Operating cash flow-$31.0M-455%
CapEx--100%
Free cash flow-$31.0M-450%

Valuation

See full
Market cap$1.02B+1,127%
Enterprise value$932M
P/S118.1×

Profitability

See full
Operating margin-6,563%-18,545pp
Net margin-8,022.9%-20,291pp
FCF margin-3,856.7%

Returns & leverage

See full
Return on equity-189.4%+139pp
Debt / equity
Current ratio11.4×+1.7×

Where this comes from

Reported directly by Asset Entities in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Asset Entities’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Asset Entities's medical device — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Asset Entities's medical device — total assets?
Asset Entities (ASST) reported medical device — total assets of $17.63M in Q1 2026.
What does medical device — total assets mean?
This metric quantifies the total value of resources, including inventory, equipment, and intellectual property, currently allocated to the medical device business segment. It reflects the capital intensity of the segment and the scale of operations dedicated to its specific product lines. Monitoring this figure helps stakeholders assess the company's asset deployment strategy and the potential for future revenue generation within this specific vertical.